Skip to main content
. 2021 Jun 11;27(16):4599–4609. doi: 10.1158/1078-0432.CCR-21-0205

Figure 2.

Figure 2. RFS stratified by UROMOL subclass. A, Entire MSK cohort. B, MSK patients treated with BCG. C, Entire UROMOL cohort. D, UROMOL patients treated with BCG.

RFS stratified by UROMOL subclass. A, Entire MSK cohort. B, MSK patients treated with BCG. C, Entire UROMOL cohort. D, UROMOL patients treated with BCG.